Pure Global AI
NCT06042634Completed

A Feasibility Study of Online Psychoeducation for Family Caregivers of People With Dementia

An Evidence-based Online Psychoeducation for Family Caregivers of People With Dementia: A Feasibility Study
Chinese University of Hong KongClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Dementia
Drug/Device/Intervention
Online psychoeducation
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Chinese University of Hong Kong
Location
Hong Kong, China
Timeline & enrollment
Phase
N/A
Start date
Jul 15, 2022
End date
Jan 31, 2023
Enrollment
60 participants
Primary outcome

Sociodemographic background,Recruitment rate,Attrition rate,Completion rate,Class attendance,Completion rate of study instrument,Satisfaction of intervention,Experience of online psychoeducation

Summary

The goal of this clinical trial is to evaluate the feasibility and acceptability of online
 psychoeducation in the family caregivers of people with dementia living in the community. The
 main objectives it aims to answer are:
 
 1. Is online psychoeducation feasible and acceptable to family caregivers of people with
 dementia?
 
 2. What is the preliminary effect of online psychoeducation on caregiving self-efficacy in
 family caregivers of people with dementia?

ICD-10 classifications
Unspecified dementiaAlzheimer diseaseDementia in Alzheimer diseaseDementia in Alzheimer disease, unspecifiedDementia in other diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06042634
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06042634 through Pure Global AI's free database. This phase not specified trial is sponsored by Chinese University of Hong Kong and is currently Completed. The study focuses on Dementia. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.